Choose language
< Return to main menu
Peptide CDMO_Quality Custom peptide synthesis_Quality

Quality

About Us

About Us

Services & Solutions

News

Resource

Contact

Career

Quality

Facilities

Quality

EHS

IP

Meeting global quality standard

Peptide synthesis company_successful US FDA inspections
9

successful US FDA inspections

2013-2021

GMP peptide manufacturing_successful EU EMA inspections
4

successful EU EMA inspections

2019-2022

Peptide manufacturingsuccessful China NMPA inspections
30+

successful China NMPA inspections

2015-2020

Peptide synthesis_successful Japan EMA inspection
4

successful Japan EMA inspection

2019-2022

Peptide CDMO_successful SwissMedic inspections
3

successful SwissMedic inspections

2018-2020

Peptide synthesis_client audits every year
300+

client audits every year

Worldwide approvals

Peptide manufacturing2013-2021
105+

country approvals for branded drugs

2013-2021

Custom peptide synthesis_2019
210+

CMC submission packages written to support global IND and NDA filings since 2019

2019

Peptide synthesis_2015-2020
1st

CDMO to support a new drug launch in China via ONE integrated CMC platform including both drug substance and drug product

2015-2020